Anupam Rasayan India Ltd reports Q2FY27 revenue of ₹821 crore, up 11% YoY
- EBITDA rose 41% to ₹202 crore; margin expanded to 25% from 19% a year earlier.
- Net profit increased 14% to ₹65 crore.
- Signed a six-year supply agreement with a US-based specialty metal manufacturer.
- Completed acquisition of a 50.07% stake in Bliss GVS Pharma.
